Greater transparency needed in publishing information from clinical trials
An initiative from the drugs regulator, the European Medicines Agency, to commit to releasing all of the information from clinical trials once the marketing authorization process has ended, which has been greeted with cautious ...
Jan 29, 2013
0
0